Glenmark Pharmaceuticals has announced that its U.S. based subsidiary, Glenmark Pharmaceuticals Inc., USA, has launched Travoprost Ophthalmic Solution USP (Ionic Buffered Solution) in the U.S. market.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
